Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Stage 0-III Melanoma



Status:Active, not recruiting
Conditions:Skin Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:12/9/2018
Start Date:March 13, 2017
End Date:January 2020

Use our guide to learn which trials are right for you!

Internet Intervention for Sun Protection and Skin Self-check Behaviors

This clinical trial studies how well an interactive tailored website works in promoting sun
protection and skin self-check behaviors in patients with stage 0-III melanoma. An
internet-based program may help individuals to perform skin self-checks and engage in sun
protection behaviors.

PRIMARY OBJECTIVES:

I. To evaluate the impact of the interactive tailored website (ITW) versus usual care on skin
self-examination (SSE) and sun protection behaviors among individuals diagnosed with
melanoma.

SECONDARY OBJECTIVES:

I. To examine mediators of the impact of the intervention. The effects of the intervention on
SSE and sun protection behaviors will be mediated by melanoma knowledge, self-efficacy for
SSE and sun protection behaviors, perceived benefits of SSE and sun protection behaviors,
perceived barriers to SSE and sun protection behaviors, and perceived controllability of
melanoma.

TERTIARY OBJECTIVES:

I. To examine moderators of the impact of the intervention. To evaluate whether ITW effects
are moderated by the following factors: time since diagnosis, disease stage, age, sex,
income, education, Internet experience, distress about melanoma, worry about recurrence, and
evaluation and usage of the ITW.

OUTLINE:

Phase I: Patients review draft website content materials in a semi-structured format and
provide feedback via open- and closed-ended questions for the development, testing, and
finalization of ITW.

Phase II: Patients are randomized into 1 of 2 arms.

ARM I: Patients access ITW and complete each module over 30-40 minutes.

ARM II: Patients receive usual care and are then offered ITW.

All patients in Phase II complete surveys over 20-40 minutes at 8, 24, and 48 weeks.

Inclusion Criteria:

- Phase I: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma

- Phase I: From 3-36 months post-surgical treatment

- Phase I: Access to the internet

- Phase I: Able to speak and read English

- Phase I: Able to provide informed consent

- Phase II: Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma

- Phase II: From 3-24 months post-surgical treatment

- Phase II: Not adherent to thorough SSE (i.e., did not check every area of the body at
least once during the past 2 months)

- Phase II: Not adherent to sun protection recommendations (i.e., mean score < 4 [which
corresponds to "often"] on a 5-point scale [from 1 = "never" to 5 = "always"] that
assesses the frequency of engaging in four sun protection behaviors)

- Phase II: Access to a computer connected to the internet

- Phase II: Able to speak and read English

- Phase II: Able to provide informed consent
We found this trial at
2
sites
Charlottesville, Virginia 22903
(434) 924-0311
Principal Investigator: Lee M. Ritterband, PhD
Phone: 434-924-5988
University of Virginia The University of Virginia is distinctive among institutions of higher education. Founded...
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
New Brunswick, New Jersey 08903
Principal Investigator: Elliot J. Coups
Phone: 732-235-8076
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials